SEARCH

SEARCH BY CITATION

References

  • 1
    Staessen JA, Wang JG, Bianchi G, Birkenhäger WH. Essential hypertension. Lancet 2003; 361: 162941.
  • 2
    Wu X, Duan X, Gu D, Hao J, Tao S, Fan D. Prevalence of hypertension and its trends in Chinese populations. Int J Cardiol 1995; 52: 3944.
  • 3
    Li LM, Rao KQ, Kong LZ, et al. A description on the Chinese national nutrition and health survey in 2002. Chin J Epidemiol 2005; 26:47884 (in Chinese).
  • 4
    Li Y, Staessen JA, Li LH, et al. Blood pressure and urinary sodium excretion in relation to the A-1984G adrenomedullin polymorphism in a Chinese population. Kidney Int 2006; 69: 11538.
  • 5
    Wang JG, Liu LF, Zagato L, et al. Blood pressure in relation to three candidate genes in a Chinese population. J Hypertens 2004; 22: 93744.
  • 6
    Zhou BF, Stamler J, Dennis B, et al. Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late 1990s: the INTERMAP study. J Hum Hypertens 2003; 17: 62330.
  • 7
    Liu L, Wang JG, Ma SP, et al. Chinese subjects entered in the Hypertension in the Very Elderly Trial (HYVET). Chin Med J 2008; 121: 150912.
  • 8
    Savage PJ, Pressel SL, Curb JD, et al. Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group. Arch Intern Med 1998; 158: 74151.
  • 9
    Franse LV, Pahor M, Di Bari M, Somes GW, Cushman WC, Applegate WB. Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program. Hypertension 2000; 35: 102530.
  • 10
    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 298197.
  • 11
    Guyton AC. Blood pressure control – special role of the kidneys and body fluids. Science 1991; 252: 18136.
  • 12
    Li Y, Wang JG, Gao PJ, et al. Are published characteristics of the ambulatory blood pressure generalizable to rural Chinese? The JingNing population study. Blood Press Monit 2005; 10: 12534.
  • 13
    Li Y, Staessen JA, Lu L, Li LH, Wang GL, Wang JG. Is isolated nocturnal hypertension a novel clinical entity? Findings from a Chinese population study. Hypertension 2007; 50: 3339.
  • 14
    Li LH, Li Y, Huang QF, Sheng CS, Staessen JA, Wang JG. Isolated nocturnal hypertension and arterial stiffness in a Chinese population. Blood Press Monit 2008; 13: 1579.
  • 15
    Fan HQ, Li Y, Thijs L, et al. Prognostic value of isolated nocturnal hypertension in 8711 subjects from 10 populations. J Hypertens 2010; 28: 203645.
  • 16
    Asia Pacific Cohort Studies Collaboration. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens 2003, 21: 70716.
  • 17
    He J, Ogden LG, Vupputuri S, Bazzano LA, Loria C, Whelton PK. Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. JAMA 1999; 282: 202734.
  • 18
    Boggia J, Li Y, Thijs L, et al. Prognostic accuracy of the day versus night ambulatory blood pressure revisited in 7458 randomly recruited subjects. Lancet 2007; 370: 121929.
  • 19
    Liu L, Wang JG, Gong L, Liu G, Staessen JA, for the Systolic Hypertension in China (Syst-China) Collaborative Group. Comparison of active treatment and placebo for older Chinese patients with isolated systolic hypertension. J Hypertens 1998; 16: 18239.
  • 20
    Wang JG, Staessen JA, Gong L, Liu L, for the Systolic Hypertension in China (Syst-China) Collaborative Group. Chinese trial on isolated systolic hypertension in the elderly. Arch Intern Med 2000; 160: 21120.
  • 21
    Gong L, Zhang W, Zhu Y, et al. Shanghai trial of nifedipine in the elderly (STONE). J Hypertens 1996; 14: 123745.
  • 22
    Liu L, Zhang Y, Liu G, et al. The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients. J Hypertens 2005; 23: 215772.
  • 23
    Wang JG, Kario K, Lau T, et al. Use of the dihydropyridine calcium channel blockers in the management of hypertension in Eastern Asians: a scientific statement of the Asian Pacific Heart Association. Hypertens Res 2011; 34: 42330.
  • 24
    Staessen JA, Wang JG, Thijs L. Cardiovascular prevention and blood pressure reduction: a meta-analysis. Lancet 2001; 358: 130515.
  • 25
    Wang JG, Li Y, Franklin S, Safar M. Prevention of stroke and myocardial infarction by amlodipine and angiotensin receptor blockers: a quantitative overview. Hypertension 2007; 50: 1818.
  • 26
    Pristipino C, Beltrame JF, Finocchiaro ML, et al. Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation 2000; 101: 11028.
  • 27
    Sueda S, Kohno H, Fukuda H, Uraoka T. Did the widespread use of long-acting calcium antagonists decrease the occurrence of variant angina ? Chest 2003; 124: 20748.